Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease

Recruiting now

Conditions studied: Diabetic Kidney Disease

In brief

The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.

Key facts

Study ID

NCT06452862

Run by

Shengjing Hospital

People needed

150

Starts

2024-06-06

Expected to finish

2028-06-06

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinically diagnosed diabetic kidney disease (DKD)
• Age 18-80 years

You may not qualify if…

• Malignant tumor, active infection, or life expectancy <1 year
• Pregnancy or lactation
• MRE contraindications (metal implants, claustrophobia, severe arrhythmia) or poor image quality
• eGFR <15 mL/min/1.73m² or receiving renal replacement therapy
• Other primary kidney diseases or systemic diseases affecting renal function

Where it is running

• Shengjing Hospital — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.